Delcath Systems, Inc. (DCTH) - Uzoq muddatli qarzning kapitalga nisbati
Delcath Systems, Inc. (DCTH) daromadlari kliniklarda Hepzato protokollarining sekin joriy etilishi va yuqori ishlab chiqish xarajatlari tufayli cheklanmoqda. Delcath Systems, Inc. (DCTH) tizimli zararni minimallashtiruvchi qon filtratsiyasiga ega bo'lgan noyob mahalliy jigar kimyoterapiya tizimini ishlab chiqdi. Ushbu tarixiy narxlar grafigi aktivning dinamikasini aks ettiradi, bunda asosiy ko'rsatkich 0.02 hisoblanadi, biznesning muvaffaqiyati esa Hepzato Kit savdolari hajmini oshirish va operatsion xarajatlarni nazorat qilishga bog'liq.
DCTH (Delcath Systems, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Delcath Systems, Inc.|DCTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati delcath.com|DCTH - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Delcath Systems, Inc.|DCTH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Delcath Systems
Kompaniyaning dastlabki tahlili:DCTH, Delcath Systems Inc
Ushbu ko'rsatkich uzoq muddatli kredit majburiyatlarining kapitalga nisbatini o'lchaydi, bu esa biznesning moliyaviy barqarorligi va uzoq muddatli istiqboldagi qarz yuklamasini baholash imkonini beradi. Hozirgi uzoq muddatli qarzning kapitalga nisbati 0.02 ni tashkil etadi, bu esa PHP tizimini ishlab chiqishning kapital intensivligi va tibbiy qurilmalarni bozorga chiqarish bo'yicha FDA ning qat'iy tartibga soluvchi talablari tufayli Delcath Systems, Inc. (DCTH) uchun o'ta muhimdir.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd.|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati RVMD (Revolution Medicines Corp)|AAPG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi cgoncology.com CGON|URGN: Uzoq muddatli qarzning kapitalga nisbati|BCAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PSNL|ERAS (Erasca Oncology) - Uzoq muddatli majburiyatlarning kapitalga nisbati|YMAB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti aurabiosciences.com (AURA)|Candel Therapeutics (CADL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Accuray Inc (ARAY)|SELLAS Life Sciences Group - Uzoq muddatli qarzning kapitalga nisbati|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Citius Oncology, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|HURA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati WHWK (Aadi Bioscience, Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati TScan|Uzoq muddatli qarzning kapitalga nisbati Champions Oncology CSBR|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi xbiotech.com (XBIT)|CVM: Uzoq muddatli qarzning kapitalga nisbati|OS Therapies Inc. - Uzoq muddatli majburiyatlarning kapitalga nisbati|RADX - Uzoq muddatli qarzning o'z kapitaliga nisbati|ARTV - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANL (adlainortye.com) - Uzoq muddatli qarzning kapitalga nisbati|verupharma.com (VERU) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TPST (Tempest Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Xilio (XLO)|Uzoq muddatli qarzning o'z kapitaliga nisbati Renovaro Inc.|Uzoq muddatli kreditlarning kapitalga nisbati muraloncology.com (MURA)|Uzoq muddatli qarzning kapitalga nisbati Kairos Pharma|OKUR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CytoMed (GDTC)|CRIS: Uzoq muddatli qarzning kapitalga koeffitsiyenti|apollomicsinc.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tharimmune Corporation|Uzoq muddatli qarzning o'z kapitaliga nisbati ADVB (Advanced Biomed Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati GNPX|CLDI (Calidi Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Sunshine Biopharma Inc. SBFM|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenetic Biosciences, Inc. (XBIO)|Uzoq muddatli kreditlarning kapitalga nisbati Salarius Pharma SLRX|PPBT (Purple Biotech) - Uzoq muddatli qarzning kapitalga nisbati|AONC: Uzoq muddatli majburiyatlarning kapitalga nisbati|BGNE (BeiGene) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CKPT (Checkpoint Therapeutics Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ELEV: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati iCAD Corp (ICAD)|Ikena Oncology, Inc. (IKNA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti notablelabs.com (NTBL)|Uzoq muddatli qarzning kapitalga nisbati VIRX|MorphoSys Inc - Uzoq muddatli qarzdorlikning kapitalga nisbati|NAYA Bio (NAYA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|AAPGV - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi